Inventor · disambiguated record
Shai Novik
Also filed as: NOVIK SHAI
14 granted patents·6 pending applications·39 citations·filing 2015–2025
89Inventor score
Files withENLIVEX THERAPEUTICS LTD8ENLIVEX THERAPEUTICS RDO LTD6Enlivex Therapeutics R&D Ltd3EYEKON E R D LTD2ENLIVEXTHERAPEUTICS LTD1
Top patents by PatentIndex Score
20 records- 0193US11596652B2Early apoptotic cells for use in treating sepsisENLIVEX THERAPEUTICS LTD·Filed 2020·Granted Mar 7, 2023·3 cites·20 claims
- 0293US10857181B2Therapeutic pooled blood apoptotic cell preparations and uses thereofENLIVEX THERAPEUTICS LTD·Filed 2016·Granted Dec 8, 2020·9 cites·22 claims
- 0392US11318163B2Combination immune therapy and cytokine control therapy for cancer treatmentENLIVEX THERAPEUTICS LTD·Filed 2019·Granted May 3, 2022·6 cites·20 claims
- 0492US11304976B2Combination immune therapy and cytokine control therapy for cancer treatmentENLIVEX THERAPEUTICS LTD·Filed 2018·Granted Apr 19, 2022·6 cites·15 claims
- 0592US11000548B2Combination immune therapy and cytokine control therapy for cancer treatmentENLIVEX THERAPEUTICS LTD·Filed 2017·Granted May 11, 2021·7 cites·6 claims
- 0690US11512289B2Combination immune therapy and cytokine control therapy for cancer treatmentENLIVEX THERAPEUTICS RDO LTD·Filed 2016·Granted Nov 29, 2022·6 cites·6 claims
- 0778US11497767B2Combination immune therapy and cytokine control therapy for cancer treatmentENLIVEX THERAPEUTICS LTD·Filed 2019·Granted Nov 15, 2022·2 cites·20 claims
- 0871US12274714B2Early apoptotic cells for use treating sepsisENLIVEX THERAPEUTICS LTD·Filed 2022·Granted Apr 15, 2025·0 cites·18 claims
- 0970US11717539B2Combination immune therapy and cytokine control therapy for cancer treatmentENLIVEX THERAPEUTICS RDO LTD·Filed 2019·Granted Aug 8, 2023·0 cites·17 claims
- 1069US2021228633A1Combination immune therapy and cytokine control therapy for cancer treatmentENLIVEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1168US2023084027A1Combination immune therapy and cytokine control therapy for cancer treatmentENLIVEX THERAPEUTICS RDO LTD·Filed 2022·Application pending·0 cites
- 1264US11883429B2Therapeutic pooled blood apoptotic cell preparations and uses thereofENLIVEX THERAPEUTICS RDO LTD·Filed 2020·Granted Jan 30, 2024·0 cites·26 claims
- 1360US2025207105A1Frozen formulation comprising apoptotic cellsEnlivex Therapeutics R&D Ltd·Filed 2023·Application pending·0 cites
- 1456US11951126B2Therapeutic apoptotic cells for cancer therapyENLIVEX THERAPEUTICS RDO LTD·Filed 2019·Granted Apr 9, 2024·0 cites·5 claims
- 1553US2023089828A1Use of early apoptotic cells for treating covid-19Enlivex Therapeutics R&D Ltd·Filed 2021·Application pending·0 cites
- 1651US2025255901A1Therapeutic apoptotic cells for treatment of osteoarthritisEnlivex Therapeutics R&D Ltd·Filed 2025·Application pending·0 cites
- 1751US2022280563A1Therapeutic apoptotic cells for treatment of osteoarthritisENLIVEXTHERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1844US11730761B2Combination immune therapy and cytokine control therapy for cancer treatmentENLIVEX THERAPEUTICS RDO LTD·Filed 2017·Granted Aug 22, 2023·0 cites·19 claims
- 1940US10390696B2Dynamic computer images for improving visual perceptionEYEKON E R D LTD·Filed 2015·Granted Aug 27, 2019·0 cites·20 claims
- 2038US10638925B2Determining vision related physical conditions from cross-parameter vision testsEYEKON E R D LTD·Filed 2015·Granted May 5, 2020·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Shai Novik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →